259 related articles for article (PubMed ID: 29030166)
1. MDPV and α-PVP use in humans: The twisted sisters.
Karila L; Lafaye G; Scocard A; Cottencin O; Benyamina A
Neuropharmacology; 2018 May; 134(Pt A):65-72. PubMed ID: 29030166
[TBL] [Abstract][Full Text] [Related]
2. Self-administration of the synthetic cathinones 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinopentiophenone (α-PVP) in rhesus monkeys.
Collins GT; Sulima A; Rice KC; France CP
Psychopharmacology (Berl); 2019 Dec; 236(12):3677-3685. PubMed ID: 31346629
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of novel synthetic stimulants structurally related to the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV).
Marusich JA; Antonazzo KR; Wiley JL; Blough BE; Partilla JS; Baumann MH
Neuropharmacology; 2014 Dec; 87():206-13. PubMed ID: 24594476
[TBL] [Abstract][Full Text] [Related]
4. The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter.
Gannon BM; Baumann MH; Walther D; Jimenez-Morigosa C; Sulima A; Rice KC; Collins GT
Neuropsychopharmacology; 2018 Nov; 43(12):2399-2407. PubMed ID: 30305739
[TBL] [Abstract][Full Text] [Related]
5. Crystallographic investigations of select cathinones: emerging illicit street drugs known as `bath salts'.
Wood MR; Lalancette RA; Bernal I
Acta Crystallogr C Struct Chem; 2015 Jan; 71(Pt 1):32-8. PubMed ID: 25567572
[TBL] [Abstract][Full Text] [Related]
6. Active vaccination attenuates the psychostimulant effects of α-PVP and MDPV in rats.
Nguyen JD; Bremer PT; Ducime A; Creehan KM; Kisby BR; Taffe MA; Janda KD
Neuropharmacology; 2017 Apr; 116():1-8. PubMed ID: 27956054
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic Activity of Pyrovalerone Derivatives, an Emerging Group of Psychostimulant Designer Cathinones.
Wojcieszak J; Andrzejczak D; Woldan-Tambor A; Zawilska JB
Neurotox Res; 2016 Aug; 30(2):239-50. PubMed ID: 27295059
[TBL] [Abstract][Full Text] [Related]
8. Current "legal highs".
Johnson LA; Johnson RL; Portier RB
J Emerg Med; 2013 Jun; 44(6):1108-15. PubMed ID: 23528960
[TBL] [Abstract][Full Text] [Related]
9. In vivo potency and efficacy of the novel cathinone α-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male rats.
Aarde SM; Creehan KM; Vandewater SA; Dickerson TJ; Taffe MA
Psychopharmacology (Berl); 2015 Aug; 232(16):3045-55. PubMed ID: 25925780
[TBL] [Abstract][Full Text] [Related]
10. Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).
Watterson LR; Kufahl PR; Nemirovsky NE; Sewalia K; Grabenauer M; Thomas BF; Marusich JA; Wegner S; Olive MF
Addict Biol; 2014 Mar; 19(2):165-74. PubMed ID: 22784198
[TBL] [Abstract][Full Text] [Related]
11. Neurobiology of 3,4-methylenedioxypyrovalerone (MDPV) and α-pyrrolidinovalerophenone (α-PVP).
Glennon RA; Young R
Brain Res Bull; 2016 Sep; 126(Pt 1):111-126. PubMed ID: 27142261
[TBL] [Abstract][Full Text] [Related]
12. Behavioral pharmacology of designer cathinones: a review of the preclinical literature.
Gregg RA; Rawls SM
Life Sci; 2014 Feb; 97(1):27-30. PubMed ID: 24231450
[TBL] [Abstract][Full Text] [Related]
13. The Cathinones MDPV and α-PVP Elicit Different Behavioral and Molecular Effects Following Acute Exposure.
Giannotti G; Canazza I; Caffino L; Bilel S; Ossato A; Fumagalli F; Marti M
Neurotox Res; 2017 Nov; 32(4):594-602. PubMed ID: 28646469
[TBL] [Abstract][Full Text] [Related]
14. Reinforcing effects of synthetic cathinones in rhesus monkeys: Dose-response and behavioral economic analyses.
de Moura FB; Sherwood A; Prisinzano TE; Paronis CA; Bergman J; Kohut SJ
Pharmacol Biochem Behav; 2021 Mar; 202():173112. PubMed ID: 33444603
[TBL] [Abstract][Full Text] [Related]
15. Relative reinforcing effects of second-generation synthetic cathinones: Acquisition of self-administration and fixed ratio dose-response curves in rats.
Gannon BM; Galindo KI; Mesmin MP; Sulima A; Rice KC; Collins GT
Neuropharmacology; 2018 May; 134(Pt A):28-35. PubMed ID: 28811192
[TBL] [Abstract][Full Text] [Related]
16. Intoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives, MDPV copycats.
Beck O; Bäckberg M; Signell P; Helander A
Clin Toxicol (Phila); 2018 Apr; 56(4):256-263. PubMed ID: 28895757
[TBL] [Abstract][Full Text] [Related]
17. Reinforcing Effects of Binary Mixtures of Common Bath Salt Constituents: Studies with 3,4-Methylenedioxypyrovalerone (MDPV), 3,4-Methylenedioxymethcathinone (methylone), and Caffeine in Rats.
Gannon BM; Galindo KI; Mesmin MP; Rice KC; Collins GT
Neuropsychopharmacology; 2018 Mar; 43(4):761-769. PubMed ID: 28677665
[TBL] [Abstract][Full Text] [Related]
18. Reinforcing and discriminative-stimulus effects of two pyrrolidine-containing synthetic cathinone derivatives in rats.
Xu P; Lai M; Fu D; Liu H; Wang Y; Shen H; Zhou W
Pharmacol Biochem Behav; 2021 Apr; 203():173128. PubMed ID: 33515585
[TBL] [Abstract][Full Text] [Related]
19. Neurocognitive dysfunction following repeated binge-like self-administration of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).
Sewalia K; Watterson LR; Hryciw A; Belloc A; Ortiz JB; Olive MF
Neuropharmacology; 2018 May; 134(Pt A):36-45. PubMed ID: 29183686
[TBL] [Abstract][Full Text] [Related]
20. Forensic investigation of K2, Spice, and "bath salt" commercial preparations: a three-year study of new designer drug products containing synthetic cannabinoid, stimulant, and hallucinogenic compounds.
Seely KA; Patton AL; Moran CL; Womack ML; Prather PL; Fantegrossi WE; Radominska-Pandya A; Endres GW; Channell KB; Smith NH; McCain KR; James LP; Moran JH
Forensic Sci Int; 2013 Dec; 233(1-3):416-22. PubMed ID: 24314548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
